In HFD-induced obesity in mice, oral administration of A. muciniphila could reverse metabolic syndrome including fat-mass gain, metabolic endotoxemia, adipose tissue inflammation, and insulin resistance without influencing food intake (65, 82). The gene discussed is INS; the disease is metabolic syndrome.